Source: business / law ip news stories aggregated by FeedZilla.com
CORAL SPRINGS, FL – Nutra Pharma Corporation, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), Human Immunodeficiency Virus (HIV), Multiple Sclerosis (MS) and Pain, announced in a press release that it has received app… (source: AG IP News) – Share on Twitter – Share on Facebook – RSS and RSS Feed on Feedzilla.com
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.